Edition:
United States

Insider Trading: Arrowhead Pharmaceuticals Inc (ARWR.OQ)

ARWR.OQ on NASDAQ Stock Exchange Global Select Market

14.51USD
17 Aug 2018
Change (% chg)

$0.18 (+1.26%)
Prev Close
$14.33
Open
$14.44
Day's High
$14.56
Day's Low
$13.99
Volume
598,139
Avg. Vol
547,052
52-wk High
$17.50
52-wk Low
$1.91

All Insider Trades
Trading Date Name Title Type Shares Traded Price
18 Jun 2018

Myszkowski (Kenneth Allen)

Chief Financial Officer Sell 20,000 $14.01
18 Jun 2018

Myszkowski (Kenneth Allen)

Chief Financial Officer Buy 20,000 $2.01
30 May 2018

Myszkowski (Kenneth Allen)

Chief Financial Officer Sell 12,600 $11.00
30 May 2018

Myszkowski (Kenneth Allen)

Chief Financial Officer Buy 12,600 $2.01
29 May 2018

Myszkowski (Kenneth Allen)

Chief Financial Officer Sell 1,400 $11.00
29 May 2018

Myszkowski (Kenneth Allen)

Chief Financial Officer Buy 1,400 $2.01
23 Apr 2018

Given (Douglas B M.D., Ph.D.)

Director Sell 25,000 $6.63
26 Mar 2018

Myszkowski (Kenneth Allen)

Chief Financial Officer Buy 20,000 $2.01
26 Mar 2018

Myszkowski (Kenneth Allen)

Chief Financial Officer Sell 20,000 $8.00
15 Mar 2018

Anzalone (Christopher Richard)

Chief Executive Officer Sell 26,000 $7.40
14 Mar 2018

Anzalone (Christopher Richard)

Chief Executive Officer Sell 100,000 $7.41
13 Mar 2018

Anzalone (Christopher Richard)

Chief Executive Officer Sell 100,000 $7.44
12 Mar 2018

Anzalone (Christopher Richard)

Chief Executive Officer Sell 100,000 $7.43
4 Mar 2018

Given (Bruce D)

Chief Operating Officer Sell 20,000 $6.73
4 Mar 2018

Myszkowski (Kenneth Allen)

Chief Financial Officer Sell 8,208 $6.66
31 Dec 2017

Waddill William D

Director Buy 25,000 $0.00
31 Dec 2017

Myszkowski (Kenneth Allen)

Chief Financial Officer Buy 75,000 $0.00
31 Dec 2017

Perry (Michael S)

Director Buy 30,000 $0.00
31 Dec 2017

Given (Bruce D)

Chief Operating Officer Buy 175,000 $0.00
31 Dec 2017

Anzalone (Christopher Richard)

Chief Executive Officer Buy 500,000 $0.00
31 Dec 2017

Given (Bruce D)

Chief Operating Officer Sell 20,000 $3.69
31 Dec 2017

O'Brien (Patrick C)

General Counsel Buy 60,000 $0.00
31 Dec 2017

Given (Douglas B M.D., Ph.D.)

Director Buy 30,000 $0.00
31 Dec 2017

Frykman (Edward W)

Director Buy 25,000 $0.00
31 Dec 2017

Leone (Peter Brian)

Officer Buy 40,000 $0.00

Institutional Holders

% Shares Owned: 59.10%
# of Holders: 154
Total Shares Held: 52,021,165
3 Mo. Net Change: 11,473,412
# New Positions: 62
# Closed Positions: 23
# Increased Positions: 106
# Reduced Positions: 53
# Net Buyers: 53

Officers & Directors

Name Age Since Current Position

Douglass Given

64 2013 Chairman of the Board

Christopher Anzalone

47 2007 President, Chief Executive Officer, Director

Kenneth Myszkowski

50 2010 Chief Financial Officer

Bruce Given

62 2011 Chief Operating Officer

Patrick O'Brien

53 2015 General Counsel

Michael Perry

57 2015 Lead Independent Director

Mauro Ferrari

58 2010 Independent Director

Edward Frykman

80 2004 Independent Director

William Waddill

61 2018 Independent Director

Chad Rubin

2017 IR Contact Officer